Search
Birinapant
go.drugbank.com/drugs/DB11782InvestigationalBirinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
Categories: Amino Acids, Peptides, and ProteinsPX-478
go.drugbank.com/drugs/DB06082InvestigationalPX-478 was effective in models of both non-small cell lung cancer and small cell lung cancer that express HIF-1 alpha. … PX-478 is a small molecule inhibitor of hypoxia inducible factor (HIF)-1 alpha currently in a clinical trial in patients with advanced metastatic cancer and lymphoma.
D-Phenylalanine
go.drugbank.com/drugs/DB02556ExperimentalAn essential aromatic amino acid that is a precursor of melanin; dopamine; noradrenalin (norepinephrine), and thyroxine. [PubChem]
Reltecimod
go.drugbank.com/drugs/DB16687InvestigationalReltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).
Categories: Amino Acids, Peptides, and Proteins, Costimulatory and Inhibitory T-Cell ReceptorsTovetumab
go.drugbank.com/drugs/DB12609InvestigationalTovetumab has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Advanced Solid Malignancies.
Categories: Amino Acids, Peptides, and ProteinsDomofenogene zalfaparvovec
go.drugbank.com/drugs/DB16810InvestigationalDomofenogene zalfaparvovec, formerly known as BMN-307, is an investigational AAV5-phenylalanine hydroxylase (PAH) gene therapy developed by BioMarin Pharmaceutical.
Efungumab
go.drugbank.com/drugs/DB16151InvestigationalEfungumab is under investigation in clinical trial NCT00217815 (Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer).
Categories: Amino Acids, Peptides, and ProteinsBacillus calmette-guerin substrain tice live antigen
go.drugbank.com/drugs/DB10343ApprovedInvestigationalBacillus calmette-guerin substrain tice live antigen is a vaccine containing attenuated live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of *Mycobacterium bovis* for percutaneous
Parsatuzumab
go.drugbank.com/drugs/DB14897InvestigationalParsatuzumab is under investigation in clinical trial NCT01366131 (Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced
Categories: Amino Acids, Peptides, and ProteinsNaratuximab emtansine
go.drugbank.com/drugs/DB15453InvestigationalNaratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia).
Categories: Amino Acids, Peptides, and Proteins